GATC Biotech Presents Novel Sequencing Approaches for Basic Science and Clinical Research at the Analytica in Munich, Germany

Hall A3, Stand 100

2 May 2016
Lois Manton-O'Byrne, PhD
Executive Editor

Product News

Europe’s leading sequencing service provider invites you to booth #100 in hall A3. Visitors will have the exclusive opportunity to meet with a team of sequencing specialists and discuss established sample-to-data solutions for analysis of whole genomes, exomes, transcriptomes, microbiomes and epigenomes among many others.

Stand visits can be complemented with a talk of next-generation sequencing (NGS) expert, Dr Bernhard Busch. The presentation, entitled “Recent Advancements in NGS and their Implications for Researchers and Clinicians”, will take place on May 10th from 11:00 to 11:30 in the Biotech Forum. Attendees will learn more about the key elements of GATCLIQUID, the company’s liquid biopsy-based service for non-invasive cancer research and diagnostics.

Besides NGS, GATC Biotech will showcase its popular Sanger sequencing services with fastest processing times and exceptional data quality, as well as MYCOPLASMACHECK, a qPCR-based test for detection of mycoplasma contamination in cell culture. GATC Biotech representatives will be happy to illustrate how outsourcing mycoplasma testing via MYCOPLASMACHECK can lead to cost-efficient, easy and accurate quality control of cell lines.

Above all, the GATC Biotech team has prepared a little surprise for all stand visitors. So stay curious – GATC is looking forward to many productive discussions with sequencing enthusiasts at the Analytica 2016 in Munich.

Find out more about GATC Sequencing Solutions.

Links

Tags

GATC Biotech Presents Novel Sequencing Approaches for Basic Science and Clinical Research at the Analytica in Munich, Germany